trypan blue has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auersperg, N; Cheng, JC; Leung, PC | 1 |
| Baldwin, W; Barrett, JC; Biermann, J; Jayadev, S; Murphy, E; Petranka, J | 1 |
| Averette, HE; Perras, J; Ramos, R; Schiano, MA; Sevin, BU; Wolloch, EH | 1 |
3 other study(ies) available for trypan blue and Ovarian Neoplasms
| Article | Year |
|---|---|
TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
Topics: Apoptosis; Benzamides; Caspase 3; Cystadenocarcinoma, Serous; Dioxoles; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphorylation; Prognosis; RNA, Small Interfering; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Trypan Blue; Tumor Suppressor Protein p53 | 2012 |
The oncostatic action of melatonin in an ovarian carcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Calcium; Cell Count; Cell Cycle; Cell Division; DNA; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Melatonin; Ovarian Neoplasms; Signal Transduction; Thiazoles; Thiosemicarbazones; Trypan Blue; Tumor Cells, Cultured | 1999 |
In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cell Cycle; Cell Survival; Cisplatin; DNA, Neoplasm; Drug Synergism; Female; Flow Cytometry; G2 Phase; Humans; Kinetics; Neoplasm Proteins; Nuclear Proteins; Ovarian Neoplasms; Pentoxifylline; Trypan Blue; Tumor Cells, Cultured | 1991 |